Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma
Condition: Advanced Mucosal Melanoma Intervention: Drug: Envafolimab combined with recombinant human endostatin and first-line chemotherapy Sponsor: Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials